Table 5. Baseline characteristics of group II.
| Characteristics | H1-antihistamines monotherapy (N = 498) | H1-antihistamines+steroid (N = 103) | p value |
| Presence of angioedema, no. (%) | <0.0001 | ||
| Urticaria alone | 351 (70.5) | 57 (55.3) | |
| Urticaria with angioedema | 142 (28.5) | 36 (35.0) | |
| Angioedema alone | 5 (1.0) | 10 (9.7) | |
| Previous treatment history, no. (%) | <0.0001 | ||
| No treatment | 162/442 (36.7) | 29/95 (30.5) | |
| H1-antihistamine | 227/442 (51.4) | 32/95 (33.7) | |
| H1-antihistamine+steroid | 53/442 (12.0) | 34/95 (35.8) | |
| Previous good response, no. (%) | |||
| H1-antihistamine | 190/225 (84.4) | 16/32 (50.0) | <0.0001 |
| H1-antihistamine+steroid | 47/53 (88.7) | 24/34 (70.6) | 0.034 |
| UAS, mean (SD) | (N = 84) | (N = 12) | |
| 3.89 (1.74) | 4.58 (1.38) | 0.191 |